There are 3484 resources available
2399P - Circulating tumor DNA and urine tumor DNA detection of minimal residual disease in upper tract urothelial carcinoma with radical nephroureterectomy: A cohort study
Presenter: Wei Xue
Session: Poster session 24
2400P - Frequency and nature of genomic alterations (GA) in ERBB2-altered urothelial bladder cancer (UBC)
Presenter: Rafee Talukder
Session: Poster session 24
2401P - Detection of molecular recurrence in early-stage bladder cancer patients using a urinary tumor DNA assay after transurethral resection of bladder tumor (TURBT)
Presenter: Ruiyun Zhang
Session: Poster session 24
2402P - Urine-based comprehensive genomic profiling reveals mutational landscape in real-world patients with bladder cancer
Presenter: Haige Chen
Session: Poster session 24
2403P - CDKN2A deletions are a mechanism for p16 inactivation in urothelial bladder carcinomas and are associated with an aggressive tumor phenotype
Presenter: Martina Kluth
Session: Poster session 24
2404P - Concordance of genomic alterations by next-generation sequencing in tumor tissue versus urinary tumor DNA and circulating tumor DNA in bladder cancer
Presenter: Song Xue
Session: Poster session 24
2405P - Prognostic significance of circulating tumor DNA in patients with urothelial carcinoma: A systematic review and meta-analysis
Presenter: Liu Haoyang
Session: Poster session 24
2407TiP - SunRISe-3: TAR-200 plus cetrelimab (CET) or TAR-200 versus intravesical bacillus Calmette-Guérin (BCG) in patients (pts) with BCG-naive high-risk non-muscle-invasive bladder cancer (HR NMIBC)
Presenter: Andrea Necchi
Session: Poster session 24
2408TiP - DISCUS: A randomised phase II study of 3 vs 6 cycles of chemotherapy followed by maintenance avelumab in advanced urothelial cancer - Wearable devices and circulating biomarkers assessing quality of life and surrogate efficacy endpoints
Presenter: Francesca Jackson-Spence
Session: Poster session 24